Australia's Deputy Chief Medical Officer says it is "likely" there is a link between the AstraZeneca vaccine and a Melbourne man being hospitalised with blood clots. Eight cases saw people suffer other types of thrombosis combined with low levels of blood platelets, which help blood clot.
The regulatory body also defended vaccination, saying no cause-and-effect relationship between Covid-19 vaccination and this case or those reported internationally has been established at this stage.
There were no reports of blood clots from the Pfizer-BioNTech vaccine, the United Kingdom regulator said, adding that "our thorough review into these reports is ongoing".
However, he said the risks of taking the AstraZeneca vaccine are still far outweighed by the risks of not getting the jab.
Germany has suspended the use of the vaccine for those under 60 after 31 cases of blood clots, a lot of them among younger and middle-aged women. He added that doctors and people who had received the AstraZeneca vaccine should be on the lookout for symptoms of the clotting events, like severe headaches or signs of a stroke.
Officer killed in US Capitol car-ramming attack
Large sections of fencing that secluded much of the surrounding area for months have only begun to come down in recent weeks. But CBS News reported that security officials had already warned congressional staffers of a threat before the auto ramming.
The move came after five new cases were recorded in the Netherlands in women aged 25 to 65 years, one of whom died.
The European Medicines Agency is expected to update its recommendation on this issue on April 7.
Britain, where the vaccine was developed with the University of Oxford, has been one of the countries worst-hit by coronavirus with almost 127,000 dead.
Over 13 lakh Covid-19 vaccine doses were administered till 8 pm on Saturday on the 78th day of the Covid-19 vaccination drive in India. Germany had taken a similar decision earlier this week.
Yesterday, Health director-general Tan Sri Dr Noor Hisham Abdullah said the Drug Control Authority (DCA) has agreed to approve the conditional registration of the Covid-19 Vaccine AstraZeneca Solution for Injection, to be supplied through the Covax facility by South Korean manufacturer SK Bioscience Co Limited, for use during an emergency.
A letter written by Health Secretary Rajesh Bhushan, to state governments and accessed by ANI said: "Various inputs have been received from different sources that in some of the CVCs (vaccination centres), some ineligible beneficiaries are being registered as HCWs and FLWs and are getting vaccinated in complete violation of the prescribed guidelines". People can not choose which one they get. It also ordered 30 million doses of the Pfizer-BioNTech vaccine the same year.